Fundamental Research Corp.

Investor Webinar

Please, join us on

August 4th, 2021 at 10 AM PST / 1 PM EST

Topic: Are you familiar with this new hemp product endorsed by Mayweather? 


Sid Rajeev, Head of Research at FRC, will share his thoughts on the rapidly growing market for cigarette alternatives. 

 Setti Coscarella, CEO of TAAT Global Alternatives, joins us to talk about their nicotine-free cigarettes and aggressive marketing plans. 

Company overview

-TAAT generated $691K in revenue in Q2-FY2021 (quarter ended April 2021), up 317% QoQ, beating our expectations. We are raising our 2021 forecast from $2.44M to $2.92M.

-Named “Best New Product” at convention in Las Vegas, Nevada. We are pleased to see TAAT products receive positive reviews from consumers. In our most recent report dated July 16, 2021, we had raised our 2021 revenue forecast from $2.44M to $2.92M.

-The company continues to market aggressively. Marketing expenses increased 192% QoQ to $2.9M in Q2. Management has not disclosed their marketing budget for this year. We are expecting a 15% increase in Q3.

-Healthy cash position of $14.2M, and zero debt, at the end of Q2.

-Applied to list common shares on the NASDAQ.

-We are expecting record revenue in Q3.



Setti Coscarella

Setti Coscarella

CEO of TAAT Global Alternatives

Sid Rajeev

Sid Rajeev

Head of Research at FRC

*FRC provides issuer paid coverage.
*Past performance is not indicative of future results.